Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.

Aramendi JL, Agredo J, Llorente A, Larrarte C, Pijoan J.

J Heart Valve Dis. 1998 Nov;7(6):610-4.

PMID:
9870193
2.

Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.

Aramendi JI, Mestres CA, Martinez-León J, Campos V, Muñoz G, Navas C.

Eur J Cardiothorac Surg. 2005 May;27(5):854-60. Erratum in: Eur J Cardiothorac Surg. 2005 Jul;28(1):188. Mestres, Carlos-Alfonso [corrected to Mestres, Carlos-Alberto].

PMID:
15848326
3.

Use of the Carpentier-Edwards porcine bioprosthesis: assessment of a patient selection policy.

Louagie Y, Noirhomme P, Aranguis E, Eucher P, Vanruyssevelt P, Buche M, Dion R, Jaumin P, Schoevaerdts JC, Chalant CH.

J Thorac Cardiovasc Surg. 1992 Oct;104(4):1013-24.

PMID:
1405658
4.
5.

Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.

Kuwaki K, Tsukamoto M, Komatsu K, Morishita K, Sakata J, Abe T.

J Heart Valve Dis. 2003 Mar;12(2):169-76.

PMID:
12701788
6.

Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.

Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM Jr, Glower DD.

Circulation. 1994 Nov;90(5 Pt 2):II214-9.

PMID:
7955256
7.

Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses.

García-Rinaldi R, Carro-Pagán C, Schaff HV, McKellar SH, Thompson JL 3rd, Quiñones J, Rodríguez-Acosta JF.

J Heart Valve Dis. 2009 Nov;18(6):617-25; discussion 626.

PMID:
20099710
8.

Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.

Brueck M, Kramer W, Vogt P, Steinert N, Roth P, Görlach G, Schönburg M, Heidt MC.

Eur J Cardiothorac Surg. 2007 Jul;32(1):108-12. Epub 2007 Apr 20.

PMID:
17449264
9.

High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, et al.

J Am Coll Cardiol. 1995 Apr;25(5):1111-9.

10.

15-year experience with the Carpentier-Edwards pericardial bioprosthesis.

Poirer NC, Pelletier LC, Pellerin M, Carrier M.

Ann Thorac Surg. 1998 Dec;66(6 Suppl):S57-61.

PMID:
9930418
11.

[Replacement of the mitral and aortic valves with bioprostheses. Long-term results].

Colombo T, Cicardi C, Peronace B, Pozzi M, Gordini V, Pellegrini A.

G Ital Cardiol. 1985 Oct;15(10):974-82. Italian.

PMID:
4092917
12.

Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.

Nuñez L, Aguado MG, Celemín D, Iglesias A, Larrea JL.

Ann Thorac Surg. 1982 Apr;33(4):354-8.

PMID:
7073379
13.

Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.

Yamak B, Iscan Z, Mavitas B, Ulus AT, Katircioglu SF, Tasdemir O, Bayazit K.

J Heart Valve Dis. 1999 Nov;8(6):665-73.

PMID:
10616246
14.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?

ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH.

J Thorac Cardiovasc Surg. 2010 May;139(5):1137-45. doi: 10.1016/j.jtcvs.2009.10.064. Epub 2010 Mar 19.

15.

Mid-term comparative follow-up after aortic valve replacement with Carpentier-Edwards and Pericarbon pericardial prostheses.

Le Tourneau T, Savoye C, McFadden EP, Grandmougin D, Carton HF, Hennequin JL, Dubar A, Fayad G, Warembourg H.

Circulation. 1999 Nov 9;100(19 Suppl):II11-6.

16.

Porcine versus pericardial bioprostheses: eleven-year follow up of a prospective randomized trial.

Chaudhry MA, Raco L, Muriithi EW, Bernacca GM, Tolland MM, Wheatley DJ.

J Heart Valve Dis. 2000 May;9(3):429-37; discussion 437-8.

PMID:
10888102
17.

Four years' experience with the Edwards-Tekna bileaflet valve prosthesis.

Calkavur T, Yagdi T, Apaydin A, Islamoglu F, Posacioglu H, Durmaz I, Ozbaran M.

J Heart Valve Dis. 2002 Mar;11(2):263-9.

PMID:
12000170
18.

Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience.

Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA.

Ann Thorac Surg. 1998 Dec;66(6 Suppl):S143-7.

PMID:
9930436
19.

Aspire porcine bioprosthesis: ten years' experience.

Hadjinikolaou L, Boehm MC, Ganner C, Kendall SW, Rosin MD, Goldsmith IR, Spyt TJ.

J Heart Valve Dis. 2005 Jan;14(1):47-53.

PMID:
15700436
20.

Thromboembolism in patients with pericardial valves in the absence of chronic anticoagulation: 12 years' experience.

García-Bengoechea JB, González-Juanatey JR, Rubio J, Durán D, Sierra J.

Eur J Cardiothorac Surg. 1991;5(11):592-7.

PMID:
1772670

Supplemental Content

Support Center